These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24927116)

  • 1. Evaluation of the humoral immune response to human leukocyte antigens in Brazilian renal transplant candidates.
    Saito PK; Yamakawa RH; Aparecida EP; da Silva Júnior WV; Borelli SD
    PLoS One; 2014; 9(6):e100270. PubMed ID: 24927116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Humoral Immune Response to Human Leukocyte Antigens in Turkish Renal Transplant Candidates and Relationship Between Autoimmune Disorders.
    Ari E; Yildirim M; Kucuk HF; Durmaz F; Dogu Z; Yavuz A; Parmaksiz E; Asicioglu E; Carin M
    Transplant Proc; 2015 Jun; 47(5):1326-30. PubMed ID: 26093711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.
    Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
    Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A, HLA-B, and HLA-DRB1 Allele and Haplotype Frequencies in Renal Transplant Candidates in a Population in Southern Brazil.
    Saito PK; Yamakawa RH; Noguti EN; Bedendo GB; Júnior WV; Yamada SS; Borelli SD
    J Clin Lab Anal; 2016 May; 30(3):258-65. PubMed ID: 25853623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HLA antibody profile of Turkish patients with end-stage renal disease.
    Karahan GE; Seyhun Y; Oguz F; Kekik C; Onal E; Caliskan Y; Bakkaloglu H; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
    Transplant Proc; 2009 Nov; 41(9):3651-4. PubMed ID: 19917361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of panel reactive antibodies in patients requiring kidney transplantation.
    Mishra MN; Baliga KV
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):495-9. PubMed ID: 23640620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel reactive antibody positivity and associated HLA antibodies in Turkish renal transplant candidates.
    Ozdemir FN; Sezer S; Akcay A; Arat Z; Turan M; Gulmus S; Kulah E; Haberal M
    Transpl Immunol; 2004 Jan; 12(2):185-8. PubMed ID: 14967317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
    Akgul SU; Ciftci HS; Temurhan S; Caliskan Y; Bayraktar A; Tefik T; Kaya IA; Canitez IO; Demir E; Yazici H; Bakkaloglu H; Aydin AE; Turkmen A; Nane I; Aydin F; Oguz FS
    Transplant Proc; 2017 Apr; 49(3):425-429. PubMed ID: 28340805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Single Sensitization Event on Human Leukocyte Antigen Alloimmunization in Kidney Transplant Candidates: A Single-Center Experience.
    Resse M; Paolillo R; Pellegrino Minucci B; Costa D; Fiorito C; Santangelo M; De Rosa P; Napoli C
    Exp Clin Transplant; 2018 Feb; 16(1):44-49. PubMed ID: 28661314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA phenotypes of ESRD patients are risk factors in the panel-reactive antibody (PRA) response.
    Heise E; Manning C; Thacker L
    Clin Transplant; 2001; 15 Suppl 6():22-7. PubMed ID: 11903382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparision of anti-HLA antibodies of kidney transplant candidates with chronic renal failure by two different methods: Flow-PRA and Luminex PRA.
    Kurtulmuş Y; Ayna TK; Soyöz M; Özyılmaz B; Tanrısev M; Afacan G; Colak H; Pirim I
    Transplant Proc; 2013 Apr; 45(3):875-7. PubMed ID: 23622575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of leukocyte and erythrocyte antigens in chronic kidney disease patients in southern Brazil.
    Yamakawa RH; Saito PK; da Silva Junior WV; de Mattos LC; Borelli SD
    PLoS One; 2014; 9(1):e84456. PubMed ID: 24409300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
    Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients.
    Hung SY; Lin TM; Chang MY; Wang HH; Lee YC; Ho LC; Chen YT; Hung CM; Liou HH
    Hum Immunol; 2014 Jun; 75(6):531-5. PubMed ID: 24607727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-A, -B, and -DRB1 allele and haplotype diversity in a cohort of Brazilian renal transplant candidates.
    Ravazzi-Gauch C; Bajay MM; Caldas HC; Abbud-Filho M
    Hum Immunol; 2016 Jun; 77(6):464-9. PubMed ID: 27108963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.